Bilaketaren emaitzak - Seligman, Stephen J
- Erakusten 1 - 20 emaitzak -- 22
- Go to Next Page
-
1
VIRUSES INDUCING CANCER: Implications for Therapy nork Seligman, Stephen J.
Argitaratua 1966Text -
2
Constancy and diversity in the flavivirus fusion peptide nork Seligman, Stephen J
Argitaratua 2008Text -
3
Predicting Clinical Effectiveness on the Basis of in Vitro Sensitivity Tests nork Seligman, Stephen J.
Argitaratua 1964Text -
4
-
5
Yellow Fever Virus Vaccine–associated Deaths in Young Women nork Seligman, Stephen J.
Argitaratua 2011Text -
6
-
7
-
8
-
9
KINETICS OF THE ACTION OF AMPICILLIN ON ESCHERICHIA COLI nork Seligman, Stephen J., Hewitt, William L.
Argitaratua 1963Text -
10
Simplified Assay for Gentamicin in the Presence of Other Antibiotics nork Alcid, David V., Seligman, Stephen J.
Argitaratua 1973Text -
11
-
12
-
13
-
14
Live Virus Vaccines Based on a Vesicular Stomatitis Virus (VSV) Backbone: Standardized Template with Key Considerations for a Risk/Benefit Assessment() nork Clarke, David K., Hendry, R. Michael, Singh, Vidisha, Rose, John K., Seligman, Stephen J., Klug, Bettina, Kochhar, Sonali, Mac, Lisa Marie, Carbery, Baevin, Chen, Robert T
Argitaratua 2016Text -
15
Adventitious Agents and Live Viral Vectored Vaccines: Considerations for Archiving Samples of Biological Materials for Retrospective Analysis nork Klug, Bettina, Robertson, James S., Condit, Richard C., Seligman, Stephen J., Laderoute, Marian P., Sheets, Rebecca, Williamson, Anna-Lise, Chapman, Louisa, Carbery, Baevin, Mac, Lisa M., Chen, Robert T.
Argitaratua 2016Text -
16
How Did Zika Virus Emerge in the Pacific Islands and Latin America? nork Pettersson, John H.-O., Eldholm, Vegard, Seligman, Stephen J., Lundkvist, Åke, Falconar, Andrew K., Gaunt, Michael W., Musso, Didier, Nougairède, Antoine, Charrel, Remi, Gould, Ernest A., de Lamballerie, Xavier
Argitaratua 2016Text -
17
Erratum for Pettersson et al., “How Did Zika Virus Emerge in the Pacific Islands and Latin America?” nork Pettersson, John H.-O., Eldholm, Vegard, Seligman, Stephen J., Lundkvist, Åke, Falconar, Andrew K., Gaunt, Michael W., Musso, Didier, Nougairède, Antoine, Charrel, Remi, Gould, Ernest A., de Lamballerie, Xavier
Argitaratua 2018Text -
18
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines nork Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.
Argitaratua 2019Text -
19
The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)() nork Chen, Robert T, Carbery, Baevin, Mac, Lisa, Chapman, Louisa, Condit, Richard C., Excler, Jean-Louis, Gurwith, Marc, Hendry, Michael, Khan, Arifa S., Khuri-Bulos, Najwa, Klug, Bettina, Robertson, Jim S, Seligman, Stephen J., Sheets, Rebecca, Williamson, Anna-Lise
Argitaratua 2014Text -
20
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains nork Condit, Richard C., Williamson, Anna-Lise, Sheets, Rebecca, Seligman, Stephen J., Monath, Thomas P., Excler, Jean-Louis, Gurwith, Marc, Bok, Karin, Robertson, James S., Kim, Denny, Michael Hendry, R., Singh, Vidisha, Mac, Lisa M., Chen, Robert T.
Argitaratua 2016Text